Articles tagged with Cancer Treatments
A new sequencing method, TET-assisted pyridine borane sequencing (TAPS), detects chemical modifications to DNA that contribute to cancer progression and resistance to therapy. The method is less damaging and more efficient than bisulfite sequencing, enabling the detection of mutations and structural variations.
A new report emphasizes the importance of transforming healthcare delivery in the US to reduce cancer burden. The study identifies goals for a high-performing healthcare system, including access to primary care, timely evidence-based treatment, and patient-centered care.
Researchers have developed a new compound that shows promise in treating multiple sclerosis by reducing inflammation and promoting neuroprotection and remyelination. The compound, based on chloroindazole, has been found to be effective in improving primary symptoms in a mouse model of the disease.
The UVA Health System is launching a program that uses telehealth to connect primary care providers in Appalachia with specialists to improve lung disease prevention, diagnosis, and treatment. Residents in the region have higher-than-average rates of lung cancer and COPD, and limited access to subspecialty physicians.
A Mayo Clinic study found that patients with a poor immune response to follicular lymphoma exhibited reduced costimulatory receptors on their T-cells, leading to shorter survival rates. The research may lead to the development of new therapies for some patients with follicular lymphoma.
A novel mobile application called MyPath uses AI to provide personalized guidance and support to breast cancer patients in rural Georgia. The app adapts to each stage of a patient's journey, offering relevant resources and suggestions based on their medical data and changing needs.
The report highlights the expanding role of interventional inflammatory bowel disease (IBD) endoscopy in managing complex conditions, such as strictures, fistulas, and colitis-associated neoplasia. This approach can help reduce or postpone surgical resection and treat postoperative adverse events.
Researchers at St. Jude Children's Research Hospital developed a method to customize and reduce drug interaction alerts in electronic health records. The study made 26 changes that affected 47% of alerts, resulting in a 40% decrease in alert overrides.
Researchers at University of Toledo have developed a mouse model that spontaneously develops type I diabetes and its complications, allowing for study of disease progression. The breakthrough has the potential to reshape how type I diabetes is studied and may lead to new treatments or a cure.
Researchers found that obstructive sleep apnea promotes a persistent low-intensity inflammatory state, damaging organs. This link could lead to more precise treatments, such as vitamin C or plant-derived antioxidants, to reverse inflammation and protect the body from future damage.
A large study found that direct-acting antiviral treatment is associated with reduced risk of mortality and hepatocellular cancer, but not decompensation of cirrhosis. Patients treated with direct-acting antivirals were 52% less likely to die prematurely than those who were untreated.
New DNA-based nanomachines can selectively target malignant cells, breaking down vital genes and inducing apoptotic death. The design allows for better interaction with folded RNA molecules, but further experiments are needed to improve specificity.
Researchers found that prostate cancer cells absorb fatty acids, increasing tumor growth, and blocking this process slows cancer development. The study suggests a possible therapeutic target for treating prostate cancer, particularly for men with aggressive disease.
Researchers discovered a novel metabolic pathway in cancer cells that produces an unusual fatty acid, sapienate, allowing them to bypass fatty acid metabolism inhibition. This finding can explain the resistance of certain cancer types to therapy and opens new avenues for targeted treatment.
A research team at Tokyo Medical and Dental University classified hepatocellular carcinoma into three distinct subgroups based on mutation patterns, gene expression, and immune system characterization. The findings suggest that each subgroup has a unique clinical profile, enabling targeted treatment approaches.
Researchers created a lab model of a blood vessel to study angiogenesis, revealing how the molecule EGFL7 influences blood vessel sprouting and integrity. The study suggests EGFL7 as a potential therapeutic target for diseases like retinopathy and cancer.
Researchers discovered 27 new molecules with significant therapeutic potential for treating fatty liver disease and obesity by activating the PPAR-delta protein. These molecules are currently undergoing pharmaceutical evaluations and show promise in improving physical endurance and reducing waistlines.
A new 3D imaging technique has revealed that pancreatic cancers can develop in two distinct types - 'endophytic' and 'exophytic' - depending on the size of the duct. This breakthrough may lead to improved treatments for pancreatic cancers by better understanding how cancer grows.
A new assay accurately measures TNF concentrations during adalimumab treatment, revealing that circulating TNF levels increase 50-fold before stabilizing. Lower TNF concentrations after the fourth week are associated with more antibodies against the drug and a lower chance of remission.
Researchers found that stroke risk factors increased by tripling the likelihood of a stroke within 10 years, with hormonal treatment and racial differences also playing a role. The study calls for targeted interventions to reduce stroke risk among post-menopausal breast cancer survivors.
Researchers engineered a virus that selectively targets and kills cancer cells, surpassing another viral treatment currently in use. The modified adenovirus, dl355, replicates more efficiently in cancer cells than normal cells, resulting in higher cancer cell kill rates.
A recent study published in Nicotine & Tobacco Research found that female smokers experience more stress and craving after viewing cellphone-delivered stress-inducing images than male smokers. This suggests that improving quit outcomes in women may require gender-specific cessation strategies. Researchers hope to use the data from this...
The National University of Singapore engineers have developed a novel bottom-up synthesis strategy to consistently construct TMD QDs of specific size, offering a cheaper and more scalable method. The synthesized MoS2 QDs demonstrate potential biomedical applications, including photodynamic therapy for cancer treatment.
The debate centers on renaming ultra-low risk cancers to avoid unnecessary investigations and treatments. Experts recommend recalibrating thresholds for cancer diagnosis to categorize very low risk cancers as benign, reducing anxiety and improving patient outcomes.
A new study reveals that cancer survivors experience greater financial burdens compared to non-cancer individuals, with younger survivors facing the most hardship. Privately insured cancer survivors with high deductible health plans without health savings accounts were particularly vulnerable to medical financial hardship.
Charité is leading three new EU-funded projects: ReSHAPE, VirtualBrainCloud, and ENDOSCAPE. The ReSHAPE project aims to develop a treatment for transplant rejection using regulatory T cells, while VirtualBrainCloud creates personalized brain simulations for neurodegenerative diseases. ENDOSCOPE develops non-viral gene delivery technolo...
Researchers conducted a randomized study involving 73 adults with mild to moderate active ulcerative colitis, finding that pooled donor FMT induced remission in 32% of patients, compared to 9% with placebo. The study used anaerobically processed stool to preserve bacteria, which survived and administered to patients.
Researchers at Sanford Burnham Prebys Medical Discovery Institute have found that muscle stem cells can give rise to cancer in DMD patients. The study identified two genes linked to the tumor's growth and suggests that treatments targeting muscle stem cells should consider potential cancer risk.
A recent study analyzed over 8,000 human tumors and discovered common molecular hallmarks of low oxygen levels, which can predict cancer aggressiveness and inform treatment decisions. The findings provide new insights into the complex relationship between hypoxia, genetic changes, and tumor evolution.
Scientists have identified a novel step in gene expression that controls the expression of genes crucial for breast cancer cell growth and tumour progression. The discovery highlights a specific modification allowing RNA polymerase II to overcome a pausing barrier, enabling the transcription of proliferation genes.
A study published in Cancer Cell found that Tinagl1, a protein-based therapy, reduced the spread of triple-negative breast cancer in mice by blocking two main pathways. The treatment is based on a naturally occurring protein and has been shown to be effective even after tumors have begun to metastasize.
Researchers developed two machine learning models to predict cancer patients' symptoms like depression, anxiety, and sleep disturbance. The models accurately predicted the severity of these symptoms throughout treatment, suggesting a potential improvement in quality of life for cancer patients.
Connexin43 is a widely distributed gap junction protein involved in myocardium disease and tumor migration. Understanding its role in these processes can provide insight into new therapeutic options for cancer and myocardial disease diagnosis and therapy.
A recent study suggests that black men diagnosed with low-risk prostate cancer (Gleason score 6) may have a more aggressive form of the disease, leading to higher mortality rates compared to non-black men. The research found a significant disparity in prostate cancer death rates between black and non-black patients with Gleason 6 cancers.
Researchers at CNIO and Hospital 12 de Octubre have discovered a potential new combination therapy for myelofibrosis, a severe haematological disease. The three-drug combination of nilotinib, prednisone, and ruxolitinib enhances the treatment's effectiveness by potentiating each other's benefits.
Researchers developed a computer model predicting prostate cancer progression using tumor genomes from nearly 300 patients. This enables clinicians to develop tailor-made treatments, potentially improving patient outcomes.
Researchers have revealed the brain mechanism behind the uncontrollable itch-scratching cycle. A small subset of neurons in the periaqueductal gray region tracks itch-evoked scratching behavior. The study provides a starting point to decipher how itch is processed and modulated in the brain.
A 29-year study found that only 12% of men with advanced prostate cancer were saved from dying by surgery, while 80% had died after 29 years. Surgery did extend life expectancy by 2.9 years, but also came with significant side effects.
A phase I/II trial found that combining nab-paclitaxel with gemcitabine significantly improved survival rates even among patients with reduced health status. The study's results suggest alternative treatment options for patients typically underrepresented in clinical trials.
A new study by University of Plymouth researchers has identified Prominin-1, a protein that plays a crucial role in stem cell activation and differentiation. The discovery highlights Prominin-1 as a potential therapeutic target for treating cancer and regenerating damaged tissues.
PSMA-targeted PET/MRI performs equally well as clinical nomograms to determine risk for advanced disease in high-risk prostate cancer patients, providing valuable information for treatment planning. The study results show whole-body imaging with 68Ga-PSMA-11 PET/MRI offers a one-stop shop for staging and guiding treatment options.
A new study found that young women with hormone receptor-positive luminal A breast cancer have a lower five-year disease-free survival rate compared to older patients. The study's authors hope their findings can inform better treatment options for this age group.
Researchers have discovered a higher risk of cervical cancer in women whose cervical cells test positive for certain high-risk human papillomavirus types but do not show any signs of cellular abnormalities. A total of 96 cases were found to develop pre-cancerous changes and 4 cervical cancers during the 9-year follow-up period.
Researchers from Charité - Universitätsmedizin Berlin studied genetic factors behind different tumor subtypes and their prognoses. They found that telomere maintenance mechanisms play a crucial role in the development of malignant tumors, enabling precise predictions of disease prognosis.
Advanced breast cancer patients with detectable PIK3CA mutations in their blood show improved progression-free survival when treated with alpelisib added to fulvestrant. Liquid biopsy analysis reveals a 45% risk reduction compared to tissue biopsy.
A new study identifies key molecular features that predict clinical outcomes in neuroblastoma patients. The research suggests a molecular classification scheme to select the best treatment for each patient, with tumors lacking telomere maintenance mechanisms considered low-risk and those with these features deemed higher-risk.
A recent study published in BMJ Open found that smokers who mainly roll their own cigarettes are less motivated to quit compared to those who mainly smoke factory-made cigarettes. The main reason for this disparity is the relatively cheap cost of RYO products, with users spending around half as much on smoking each week.
New research reveals that financial difficulties are a significant strain on cancer patients, with over 20% reporting financial trouble. The study found that employment status and cancer type significantly impact financial well-being.
The new guidelines from the European Hematology Association and European LeukemiaNet provide standardized approaches to clinical management of Chronic Myelomonocytic Leukemia (CMML). The recommendations are based on expert consensus and include steps to improve evidence supporting clinical guidelines.
The new UK skin cancer database reveals over 45,000 cutaneous squamous cell carcinomas (cSCC) occur every year in England, significantly higher than previously estimated. This data enables researchers to evaluate the effectiveness of prevention initiatives and treatment options for this common form of skin cancer.
Researchers have reported promising preliminary results for cryoablation as a treatment for low-risk breast cancers, with a 99.4% success rate and no serious adverse events. The procedure is being studied as an alternative to surgical lumpectomy.
Healthy blood stem cells exhibit a similar number of DNA mutations as those found in leukemic cells, suggesting that the location of these mutations is more relevant than their quantity. This study's findings have implications for understanding the origins of leukemia and developing targeted treatments.
Researchers use big data from medical studies and large biobanks to develop models predicting biological age, aging rate, and potential targets for future anti-aging therapies. The approach also led to the identification of wearable-based biomarkers of aging and frailty.
The American Society of Hematology has released new clinical practice guidelines for venous thromboembolism, covering evidence-based recommendations for prevention, diagnosis, and treatment. The guidelines aim to improve care for patients with blood clots, addressing current uncertainties and variations in clinical practice.
Researchers used big data from human medical studies and physics approaches to develop novel anti-aging therapeutics and biomarkers of aging. The strategy involves analyzing data from large biobanks and applying concepts from complex dynamic systems to predict biological age, aging rate, and potential targets for therapies.
A randomised controlled trial found that gut-directed hypnotherapy delivered by psychologists was effective in relieving IBS symptoms, with benefits persisting at 9-month follow-up. Group hypnotherapy was as effective as individual sessions, potentially offering a new treatment option for IBS patients.
A research team at Hokkaido University found that lower TRIM29 levels correlate with more mobile and invasive squamous cell carcinoma cells, leading to a worse prognosis. The TRIM-29/keratin interaction plays a crucial role in regulating cell shape and motility.
The OARtrac radiation treatment monitoring system has been awarded a 2018 R&D 100 Award for its innovative application of scintillating fiber material. The system, developed by RadiaDyne and Jefferson Lab, allows clinicians to monitor and adjust radiation delivery to patients.
The Patient-Centered Outcomes Research Institute (PCORI) has approved $54 million to fund 12 new studies comparing different treatments for various conditions, including post-traumatic stress disorder and age-related hearing loss. These studies aim to answer important questions that can inform patient care and outcomes.
A portable device that can screen for cervical cancer using a smartphone has been developed by researchers at the University of Arizona. The device is estimated to be less than $3,000 and can analyze images automatically, recommend treatment, and identify potentially cancerous areas. Its affordability, portability, and ease of use make...